I agree that this site is using cookies. You can find further informations here.
X
Hong, Ruey-Long
381  results:
Search for persons X
?
1

Betel-nut chewing does not influence PD-L1 expression rates..:

Hong, Ruey-Long ; Yen, Chia-Jui ; Lien, Ming-Yu...
Oral Oncology.  152 (2024)  - p. 106760 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Clinical decision pathway and management of locally advance..:

Guo, Ye ; Nakashima, Torahiko ; Cho, Byoung Chul...
Oral Oncology.  148 (2024)  - p. 106657 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Sequential multimodal treatments with chemotherapy and surg..:

Chen, Ching-Tso ; Chen, Hsing-Wu ; Lin, Wei-Hsin...
Journal of the Formosan Medical Association.  , 2024
Link: https://doi.org/10.1016/..
 
?
4

Clinical efficacy and biomarker analysis of dual PD-1/CTLA-..:

Lim, Darren Wan-Teck ; Kao, Hsiang-Fong ; Suteja, Lisda...
Nature Communications.  14 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
5

A Phase 1b/2 Study of Alpelisib in Combination with Cetuxim..:

Razak, Albiruni R. Abdul ; Wang, Hung-Ming ; Chang, Jang-Yang...
Targeted Oncology.  18 (2023)  6 - p. 853-868 , 2023
Link: https://doi.org/10.1007/..
 
?
6

Role of chemotherapy in patients with nasopharynx carcinoma..:

Petit, Claire ; Lee, Anne ; Ma, Jun...
The Lancet Oncology.  24 (2023)  6 - p. 611-623 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Afatinib and Pembrolizumab for Recurrent or Metastatic Head..:

Kao, Hsiang-Fong ; Liao, Bin-Chi ; Huang, Yen-Lin...
Clinical Cancer Research.  28 (2022)  8 - p. 1560-1571 , 2022
Link: https://doi.org/10.1158/..
 
?
8

Short-course pembrolizumab and continuous afatinib therapy ..:

Kao, Hsiang-Fong ; Huang, Huai-Cheng ; Liao, Bin-Chi.
BMC Cancer.  22 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
9

Posterior Reversible Encephalopathy Syndrome after Lenvatin..:

Tseng, Yu-Ju ; Chen, Chun-Nan ; Hong, Ruey-Long..
Brain Sciences.  13 (2022)  1 - p. 33 , 2022
Link: https://doi.org/10.3390/..
 
?
10

Pembrolizumab alone or with chemotherapy for recurrent or m..:

Rischin, Danny ; Harrington, Kevin J. ; Greil, Richard...
Oral Oncology.  128 (2022)  - p. 105815 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Polatuzumab vedotin–based salvage immunochemotherapy as thi..:

Wang, Yu-Wen ; Tsai, Xavier Cheng-Hong ; Hou, Hsin-An...
Annals of Hematology.  101 (2021)  2 - p. 349-358 , 2021
Link: https://doi.org/10.1007/..
 
?
12

A Clinicopathological Study of Cytomegalovirus Lymphadeniti..:

Yu, Shan-Chi ; Ko, Kuan-Yin ; Teng, Shu-Chun...
Infectious Diseases and Therapy.  10 (2021)  4 - p. 2661-2675 , 2021
Link: https://doi.org/10.1007/..
 
?
13

The impacts of intra-arterial chemotherapy on head and neck..:

Kuan, Chen-Hsiang ; Chung, Ming-Jui ; Hong, Ruey-Long...
Journal of the Formosan Medical Association.  119 (2020)  10 - p. 1524-1531 , 2020
Link: https://doi.org/10.1016/..
 
?
14

Pembrolizumab alone or with chemotherapy versus cetuximab w..:

Burtness, Barbara ; Harrington, Kevin J ; Greil, Richard...
The Lancet.  394 (2019)  10212 - p. 1915-1928 , 2019
Link: https://doi.org/10.1016/..
 
?
15

Co-Encapsulation of Chlorin e6 and Chemotherapeutic Drugs i..:

Peng, Po-Chun ; Hong, Ruey-Long ; Tsai, Tsuimin.
Pharmaceutics.  11 (2019)  11 - p. 617 , 2019
Link: https://doi.org/10.3390/..
 
1-15